Hostname: page-component-8448b6f56d-gtxcr Total loading time: 0 Render date: 2024-04-24T00:24:31.168Z Has data issue: false hasContentIssue false

The effects of growth hormone and IGF-1 deficiency on cerebrovascular and brain ageing

Published online by Cambridge University Press:  06 February 2001

WILLIAM E. SONNTAG
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
COLLEEN LYNCH
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
PHILLIP THORNTON
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
AMIR KHAN
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
SEAN BENNETT
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
RHONDA INGRAM
Affiliation:
Department of Physiology and Pharmacology, Wake Forest University School of Medicine, Winston-Salem, NC, USA
Get access

Abstract

Research studies clearly indicate that age-related changes in cellular and tissue function are linked to decreases in the anabolic hormones, growth hormone and insulin-like growth factor (IGF)-1. Although there has been extensive research on the effects of these hormones on bone and muscle mass, their effect on cerebrovascular and brain ageing has received little attention. We have also observed that in response to moderate calorie restriction (a treatment that increases mean and maximal lifespan by 30–40%), age-related decreases in growth hormone secretion are ameliorated (despite a decline in plasma levels of IGF-1) suggesting that some of the effects of calorie restriction are mediated by modifying the regulation of the growth hormone/IGF-1 axis. Recently, we have observed that microvascular density on the surface of the brain decreases with age and that these vascular changes are ameliorated by moderate calorie restriction. Analysis of cerebral blood flow paralleled the changes in vasculature in both groups. Administration of growth hormone for 28 d was also found to increase microvascular density in aged animals and further analysis indicated that the cerebral vasculature is an important paracrine source of IGF-1 for the brain. In subsequent studies, administration of GHRH (to increase endogenous release of growth hormone) or direct administration of IGF-1 was shown to reverse the age-related decline in spatial working and reference memory. Similarly, antagonism of IGF-1 action in the brains of young animals impaired both learning and reference memory. Investigation of the mechanisms of action of IGF-1 suggested that this hormone regulates age-related alterations in NMDA receptor subtypes (e.g. NMDAR2A and R2B). The beneficial role of growth hormone and IGF-1 in ameliorating vascular and brain ageing are counterbalanced by their well-recognised roles in age-related pathogenesis. Although research in this area is still evolving, our results suggest that decreases in growth hormone and IGF-1 with age have both beneficial and deleterious effects. Furthermore, part of the actions of moderate calorie restriction on tissue function and lifespan may be mediated through alterations in the growth hormone/IGF-1 axis.

Type
Review
Copyright
© Anatomical Society of Great Britain and Ireland 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)